DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Tha…

Study results were recently shared at the Society of Surgical Oncology (SSO) 2026 Annual Meeting in Phoenix. NCCN Cutaneous ...
Nasdaq

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?

Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 5.7% in the last trading session to close at $22.36. The move was backed by solid volume with far more shares changing hands than in a normal ...
ascopubs.org

Which Patients with Sentinel Node–Positive Breast Cancer Can Avoid Axillary Dissection?

Obesity and Its Impact on Breast Cancer: Tumor Incidence, Recurrence, Survival, and Possible Interventions Table 1. Results of SLN Biopsy with and without ALND, by Size of SLN Metastasis, in ...